Artivion, Inc.
Kennesaw, GA
- UEI
- L23KYFC21D68
- CAGE
- 0HSC8
- Primary NAICS
- 621991 Blood and Organ Banks
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- LMDMMFECQSN3
- Austin, TX TGU1PZG45JM5
-
- SAM.gov registration date
- Physical address
- 1655 Roberts Blvd, Kennesaw, GA 30144, USA
- Website
- artivion.com
- Founded
- 1984
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $50,250 |
| FY2026 | $436,154 |
| FY2025 | $681,418 |
| FY2024 | $787,514 |
| FY2023 | $1,089,022 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $486,404 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Protein hydrogel for use in trauma | Department of Defense | -$958,701 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Edwards Lifesciences LLC | Irvine, CA | 339112 Surgical and Medical Instrument Manufacturing |
| Endologix LLC | Santa Rosa, CA | 339113 Surgical Appliance and Supplies Manufacturing |
| Lemaitre Vascular, Inc. | Burlington, MA | 339112 Surgical and Medical Instrument Manufacturing |
| T C V S | Ann Arbor, MI | 339112 Surgical and Medical Instrument Manufacturing |
| On-X Life Technologies Inc. | Austin, TX | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
About the company
Artivion, Inc., a for-profit medical device manufacturer headquartered in Kennesaw, Georgia, supplies prosthetic heart valves, vascular grafts, saphenous vein allografts, aortic conduits, and related cardiac and vascular surgical implants directly to the Department of Veterans Affairs as a prime contractor across multiple Veterans Integrated Service Networks, with all awards issued under full-and-open competition and no set-asides applied.
Artivion operates with 100% prime contract footprint—2,585 awards spanning 1989 to September 2026—under NAICS 339113 (Surgical Appliance and Supplies Manufacturing) and PSC 6515 (Medical and Surgical Instruments, Equipment, and Supplies). The company manufactures products vertically integrated; no subcontractor involvement is identified across the award portfolio. Two named subsidiaries, On-X Life Technologies Inc. and Cardiogenesis Corporation, carry product-line designations within the parent's cardiac surgical implant portfolio. Recent representative work includes a $277,875 single-award indefinite-delivery contract with Veterans Integrated Service Network 17 for mechanical heart valves through September 2031 (awarded September 2026), a $350,000 single-award indefinite-delivery contract with VISN 21 for ON-X heart valves and aortic prostheses with consignment inventory at VA Palo Alto Health Care System through November 2027 (awarded June 2026), and a $939,600 blanket purchase agreement with VISN 15 for heart valves and related surgical implants through June 2029 (awarded June 2024). Individual purchase orders span 2023–2026 with values typically ranging from $10,000 to $50,000 for prosthetic pulmonary valves, saphenous vein grafts, femoral artery implants, and related devices.
Customer concentration is extreme and singular: 40% of awards (1,036 awards, covering 35% of combined potential value) flow to five regional VA networks—VISN 21 (292 awards, $4.2 million), VISN 10 (242 awards, $3.1 million), VISN 17 (183 awards, $2.9 million), VISN 23 (161 awards, $2.1 million), and VISN 22 (158 awards, $1.3 million). The remaining 1,549 awards distribute across 25 other federal agencies and VA regional networks, each representing smaller transaction volume. All top customers are Veterans Affairs regional networks; no DoD prime work appears. A single award to the Defense Health Agency for $22,500 in May 2025 for hardware implantation units at Walter Reed National Military Medical Center, plus scattered Defense Health Agency orders for ON-X mechanical valves (valued $5,500 to $11,000) in late 2023, comprise the only non-VA federal activity.
Artivion's recent activity trajectory shows contraction: 68 awards in 2022, 78 in 2023, 55 in 2024, 36 in 2025, and 16 awards year-to-date in 2026 (as of mid-September). Combined potential value across the full award portfolio is $39.1 million, with $24.7 million (63%) obligated. Three awards with completion dates in the next twenty-four months carry a recompete cliff exposure of $120 thousand combined potential value. The company holds no stated parent vehicles, GWACs, or GSA schedules; work flows entirely through VA regional networks via single-award and blanket purchase agreements negotiated directly with individual VISNs and spot purchase orders issued under full-and-open competition.
Quick answers
Is Artivion, Inc. registered in SAM.gov?
Yes. Artivion, Inc.'s SAM.gov registration is active through March 3, 2027.
How much has Artivion, Inc. received in federal contracts?
Federal contracts obligated $681,418 to Artivion, Inc. in fiscal year 2025 and $3,044,358 in fiscal years 2023 through 2027.
How does Artivion, Inc. rank among federal contractors?
Artivion, Inc. ranked #63 in NAICS 621991 in FY2025.
What is Artivion, Inc.'s most recent federal award?
Artivion, Inc.'s most recent federal contract award is Prosthetic: implant (36C26127P0092), from Veterans Integrated Service Network 21 (VHA), on October 23, 2026.
On GovTribe
See Artivion, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors